These findings suggested CRYAB should be considered a new regulator of lung cancer invasion and metastasis via ERK1/2/Fra-1/slug signaling; combination of the microfluidic chip and proteomics is a robust platform for assessing the lung cancer microenvironment. The gene discussed is SNAI2; the disease is lung carcinoma.